Does Aspirin Use Influence Exacerbations and Morbidity of Chronic Obstructive Pulmonary Disease?

Synopsis: Aspirin use has led to an improvement in mortality rate in coronary artery disease (CAD) patients, but there are not many studies showing mortality benefit in chronic obstructive pulmonary disease (COPD) patients. A recent observational cohort study assessed its influence on acute exacerbation of COPD, respiratory morbidity, and quality of life. The results showed a promising therapeutic use for aspirin, but further randomized controlled trials are necessary for a more definitive answer. Source: Fawzy A, Putcha N, Aaron CP, et al. Aspirin use and respiratory morbidity in COPD: a propensity score-matched analysis in subpopulations and intermediate outcome measures in COPD study. Chest. 2018.
Source: Clinical Pulmonary Medicine - Category: Respiratory Medicine Tags: Pulmonary Trends Source Type: research